KBC Securities - Hyloris Pharmaceuticals (HYL) Hyloris FIRST LOOK: New pipeline addition with RedHill valacyclovir PDUFA set

Report

KBC Securities

Jacob Mekhael ...

Thomas Vranken

Hyloris FIRST LOOK: New pipeline addition with RedHill & valacyclovir PDUFA set

Hyloris announced a new licensing agreement with RedHill Biopharma to bring in ex-US rights for ondansetron ER, a serotonin blocker that provides relief from nausea and vomiting with chemotherapy, radiotherapy and post-operative recovery. Meanwhile, the FDA accepted oral liquid valacyclovir's regulatory submission for review with a PDUFA date set for October 12, 2025. We intend to incorporate ondansetron ER in a future update of our model and look forward to the valacyclovir decision, while reiterating our Hold rating and € 5 TP.

25/02/2025 1 EN

Underlying

Hyloris Pharmaceuticals

See profile

BE0974363955 Euronext Brussels Belgium

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Jacob Mekhael

Thomas Vranken

Other Reports on these Companies

KBC Securities

Hyloris FIRST LOOK: Collaboration with AFT to develop HY-094 for iron deficiency

Hyloris entered into a late-stage research and development program in collaboration with AFT to introduce an injectable iron deficiency therapy (HY-094) to the global market – development costs and net margin from sales and licensing will be distributed equally. This announcement brings a new later stage product to the company's pipeline, for which Hyloris expects phase 3 development to start in the near-term. Given the size of the market, we expect this will be a high volume product and Hyloris will need to find a commercialisation partner with a large footprint. We note that Hyloris previous...

March 31, 2025 March 31, 2025 1 EN

KBC Securities

Morning Notes : HYL BB

: HYL BB

March 31, 2025 March 31, 2025 1 EN

KBC Securities

Hyloris FIRST LOOK: FY24 results come with a detailed pipeline update

Hyloris reported FY24 results with YE24 cash of € 23.6m (YE23: € 30.4m). Revenue grew to € 8.5m (from € 2.1m), though we note this included one-off milestone payments ($ 2.1m as well as an additional undisclosed amount). We are encouraged by the planned 9 regulatory submissions by YE26, though point out that US filing fees range $ 2-4m. Additionally, Hyloris will require extra funding to commercialise the near-term cardiology products in the US and is exploring multiple options. As such, while we acknowledge the company's operational progress, we'll look to see how Hyloris' funding plans evolv...

March 21, 2025 March 21, 2025 1 EN

Morning Notes : WDP BB, DEME BB

: WDP BB, DEME BB

6h / 14m 6h / 14m 1 EN

Wim Lewi

Wim Lewi

Warehouses De Pauw New pre-let projects in NL and RO, despite tariff turmoil

WDP announced over EUR 100m in new pre-let development projects across its land reserves in Ridderkerk (NL) and Bucharest-Dragomire?ti (RO). These projects will cover a total lettable area of approximately 93k sqm and are expected to generate an average NOI yield of more than 7.5%. The developments will cater to clients in food logistics and third-party logistics services. In Ridderkerk, WDP will develop a refrigerated logistics center for Kivits Logistics Group BV, with an investment budget of EUR 55m. In Bucharest-Dragomire?ti, WDP will expand with two warehouses for a total investment budge...

6h / 26m 6h / 26m 1 EN

Guy Sips

Guy Sips

DEME Acquiring Norwegian Havfram, active in Offshore Wind for € 900m

DEME announced that it has signed an agreement to acquire Havfram (employing around 50 people), an international offshore wind contractor based in Norway. The agreement represents an aggregated transaction value of +/- 900m including the remaining Capex needed to complete 2 vessels. This strategic acquisition aligns with DEME's ambition to expand its footprint in the offshore wind energy market and enhances its competitive positioning in turbine and foundation installations. We maintain our Buy and € 175 TP.

6h / 43m 6h / 43m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Hyloris FIRST LOOK: New pipeline addition with RedHill & valacyclovir PDUFA set

We are a financial services provider for several types of professional clients, each with distinct needs.

Hyloris FIRST LOOK: Collaboration with AFT to develop HY-094 for iron deficiency

Morning Notes : HYL BB

Hyloris FIRST LOOK: FY24 results come with a detailed pipeline update

Morning Notes : WDP BB, DEME BB

Warehouses De Pauw New pre-let projects in NL and RO, despite tariff turmoil

DEME Acquiring Norwegian Havfram, active in Offshore Wind for € 900m

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe